Abstract:In conclusion, rhabdomyolysis is developed without specific causes in patients with LC, and it is serious and often fatal particularly in cases in which acute renal failure and severe hepatic dysfunction exist. Our results indicate that LC is the underlying disease for the development of rhabdomyolysis.
“…This potential mechanism was raised on the basis of a case reporting a chronological relationship between treatment with rifaximin and rhabomyolysis in a patient with cirrhosis [26]. However, the possibility of muscle toxicity due to rifaximin seems remote due the following reasons: 1/ no cases of rhabomyolisis were reported in the pivotal trial of rifaximin for prevention of recurrent of HE and its long-term followup [15]; 2/ as of July 2019, only two cases of rhabdomyolisis possibly related to rifaximin have been collected in postmarketing safety databases of AlfaSigma (Bologna, Italy) over more than 10 years; 3/ rhabdomyolisis has been reported in the setting of advanced cirrhosis and is idiopathic in 25 to 58% of cases [27]; therefore, cause-effect relationship is difficult to establish; and 4/ no muscle toxicity was found in animal studies in rats and dogs treated with doses of rifaximin equivalent to those used in humans [28].…”
Grant support and Acknowledgements: This work has been supported by funding from EU H2020 Research & Innovation programme, No. 731875 (LIVERHOPE).We acknowledge Nicola Van Berckel for her administrative support and her valuable collaboration with the development of the Liverhope Project.
“…This potential mechanism was raised on the basis of a case reporting a chronological relationship between treatment with rifaximin and rhabomyolysis in a patient with cirrhosis [26]. However, the possibility of muscle toxicity due to rifaximin seems remote due the following reasons: 1/ no cases of rhabomyolisis were reported in the pivotal trial of rifaximin for prevention of recurrent of HE and its long-term followup [15]; 2/ as of July 2019, only two cases of rhabdomyolisis possibly related to rifaximin have been collected in postmarketing safety databases of AlfaSigma (Bologna, Italy) over more than 10 years; 3/ rhabdomyolisis has been reported in the setting of advanced cirrhosis and is idiopathic in 25 to 58% of cases [27]; therefore, cause-effect relationship is difficult to establish; and 4/ no muscle toxicity was found in animal studies in rats and dogs treated with doses of rifaximin equivalent to those used in humans [28].…”
Grant support and Acknowledgements: This work has been supported by funding from EU H2020 Research & Innovation programme, No. 731875 (LIVERHOPE).We acknowledge Nicola Van Berckel for her administrative support and her valuable collaboration with the development of the Liverhope Project.
“…It may be related to altered metabolism due to hepatic dysfunction [34]. Even though not a disease "per se", acute myopathy can develop in liver cirrhosis [31]. A subclinical myopathy cannot be excluded in our patient (muscle biopsies were not performed), but no specific muscular symptoms or laboratory signs suggestive for rhabdomyolysis were recorded at any time before transplantation.…”
Section: Idiopathic Rhabdomyolysismentioning
confidence: 96%
“…The mortality rate in this group is high, 31% vs. 10-12% in the general population [31]. Another feature is the recurrence of these episodes as well as the lack of any obvious causes [32].…”
In this report we present a fatal case of severe rhabdomyolysis during early recovery following a complicated but successful orthotopic liver transplantation. The key point in this case is skin necrosis and we consider that the clinical association of rhabdomyolysis and skin necrosis is a consequence of terlipressine induced severe vasoconstriction. A literature search was performed, in an attempt to identify similar cases as well as other plausible explanations.
“…3,4,[7][8][9] In diabetic patients, the well-known vascular changes-such as microangiopathy, atheroma embolization, or vascular occlusion with consequent muscle edema, which reduces capillary blood flow-may contribute to muscle injury. 9 One case series reported that idiopathic rhabdomyolysis often occurs in patients with liver cirrhosis and suggested that defective muscle metabolism due to hepatic dysfunction results in rhabdomyolysis in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…9 One case series reported that idiopathic rhabdomyolysis often occurs in patients with liver cirrhosis and suggested that defective muscle metabolism due to hepatic dysfunction results in rhabdomyolysis in these patients. 8 Acute and chronic alcohol intoxication also has direct toxicity to muscle. 3,7 It was reported that multiple causes were present in 60% of patients assayed and multiple muscle insults are usually needed to produce rhabdomyolysis unless an underlying myopathy is present.…”
Introduction: Rhabdomyolysis is very rare in laparoscopic partial resection surgery of the liver. The muscles of the buttock, shoulder girdles, or back are usually injured with the patient in the supine position.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.